Concepedia

Yukio Kadokawa

YK

Statistics

Publications

2

Citations

42

H-Index

2

Active since

2021

Affiliations

Osaka International Cancer Institute(Current)

Yukio Kadokawa is an author at Osaka International Cancer Institute specializing in immunotherapy safety, cancer immunotherapy, and pharmacy.

ORCID

Publications per year

2021–2023

2

Publications

2

Efficacy and safety of Infliximab for steroid‑resistant immune‑related adverse events: A retrospective study

Yukio Kadokawa, Mari Takagi, Tomoe Yoshida et al. · Molecular and Clinical Oncology · 2021 · 27 citations · Full text

, , +16

Efficacy and safety of mycophenolate mofetil in treating immune‐related hepatitis induced by immune checkpoint inhibitor use: A retrospective study

Yukio Kadokawa, Satoko Inoue, Akitoshi Tatsumi et al. · JGH Open · 2023 · 15 citations · Full text

, , +12

1–2 of 2